Jay Fishman dropping ID pearls at American Society of Transplantation (AST) fellows symposium. My personal take home message from this:1-Involve your friendly ID consult team early 2-Help out your friendly ID team by obtaining tissue. Or in the words of Francisco Marty, MD #dontcoverdiscover #ASTfellows2019 #TxID

Great diagnoses at Ped ID Fellows Day: Balamuthia; EBV lymphoid granulomataosis; Fusobacterium; and more!

Compassionate use phage therapy for MDR infections in transplant patients. Great stuff.

Great talk from Matthew Memoli at #IDWeek2019. Importance of all influenza vaccine studies including basic mechanistic investigation to understand why vaccines do or don’t work and how to improve them.

Novel influenza vaccines being developed that enhance cellular immunity response to vaccination. #IDWeek2019

Intriguing results

Good stuff!

Open label RCT of lopinavir/ritonavir + SOC versus SOC alone in adults in China. No difference between groups. Median duration of symptoms at start of treatment was 13 days. nejm.org/doi/full/10.10…

Questions about tocilizumab - 1. The anecdotal reports seem impressive. Are there any case series published or in development on its use in the US? 2. Why hasn't the first series from China been published in a peer-reviewed journal yet? chinaxiv.org/abs/202003.000…

1/n I am asked on a daily basis about IL-6 blockade in #COVID19 patients @sloan_kettering . The truth is that I don't know if this intervention is helpful, neutral, or harmful. Colleagues point to the role of IL-6 blockade in treating CAR T cell toxicities and its cytokine storm.

Incredibly useful data on COVID19 in SOT coming from UW.